Loading…
Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer
Immunohistochemistry (IHC) is a cheap and rapid method to detect p53 inactivation but the results are often discordant with gene mutation analysis. This study aimed to investigate whether there is a difference in the immunohistochemical staining patterns of p53‐positive cells on comparing tumours wi...
Saved in:
| Published in: | The Journal of pathology 2000-03, Vol.190 (4), p.450-456 |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | cdi_FETCH-LOGICAL-c4705-b2a19c0849b9c5de3a298338d8eab716885e5faf4409993ca8881c40ac89f63a3 |
| container_end_page | 456 |
| container_issue | 4 |
| container_start_page | 450 |
| container_title | The Journal of pathology |
| container_volume | 190 |
| creator | Kaserer, Klaus Schmaus, Judith Bethge, Ulrike Migschitz, Brigitte Fasching, Sabine Walch, Axel Herbst, Friedrich Teleky, Bela Wrba, Fritz |
| description | Immunohistochemistry (IHC) is a cheap and rapid method to detect p53 inactivation but the results are often discordant with gene mutation analysis. This study aimed to investigate whether there is a difference in the immunohistochemical staining patterns of p53‐positive cells on comparing tumours with inactivating gene mutations with those without. Tissues of 142 colorectal cancers were investigated for p53 inactivation simultaneously by IHC and gene analysis using SSCP of exons 4–9 and sequencing. In addition, tumours were investigated immunohistochemically for the expression of mdm‐2 protein, known to be transcriptionally transactivated by the wild‐type (wt) p53 gene. p53‐positive cells of tumours without detectable p53 gene mutations were microdissected using a PALM laser microscope system and subjected to p53 sequence analysis. Among the 142 cases of colorectal cancer (male/female=88/54; mean age 66a±11 years, range 24–90 years), 74% (n=105) of tumours were positive by p53 IHC and mutations in the p53 gene were found in 51% (73 patients). In 16% (12 patients) with mutations in the p53 gene, IHC for p53 was negative. In tumours with mutations in the p53 gene and positive p53 IHC, staining of all nuclei of the tumour was more frequently (57/61, 93%) found than in tumours without p53 gene mutations, where staining of scattered single cells was predominantly seen (29/44, 66%; p |
| doi_str_mv | 10.1002/(SICI)1096-9896(200003)190:4<450::AID-PATH545>3.0.CO;2-8 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70947975</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17505786</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4705-b2a19c0849b9c5de3a298338d8eab716885e5faf4409993ca8881c40ac89f63a3</originalsourceid><addsrcrecordid>eNqFkVFv0zAUhSMEYmXwF1AeENoeUuzYju2CEKWwrVJFJ1bEBA9Xruu0hjQpdirov-eWlIEE0vxyrXuPj47vlySvKOlTQvJnJ1fj0fiUEl1kWuniJCd42CnVZMBfcEEGg-H4TXY5nF0ILl6yPumPps_zTN1JejeP7iY9tMozxqk8Sh7E-AU9tBbifnJESaHx8F6yuGqNr329TDembV2oY9qU6Uaw1K_X27pZ-dg2duXWWMMuNfUibVfOh3Tum6pZemuqNPpl7Uu81talvk4tToKzLY5-9cLD5F5pqugeHepx8uHs7Wx0kU2m5-PRcJJZLonI5rmh2hLF9VxbsXDM5FoxphbKmbmkhVLCidKUnOM_NLNGKUUtJ8YqXRbMsOPkaee7Cc23rYstYGzrqsrUrtlGkERzqaW4VUilIEKqAoXXndCGJsbgStgEvzZhB5TAHhXAHhXstw77rUOHChAVcEBUAIgKDqiAAYHRFHJQaP34kGE7X7vFX8YdGxQ8OQhMxDWXAXfp4x9drmVOCco-d7LvvnK7f_LdFu__6X630D3r3JG_-3HjbsJXKCSTAj6-O4fXs09nl3zyHq7ZT_TCzPc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17505786</pqid></control><display><type>article</type><title>Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Kaserer, Klaus ; Schmaus, Judith ; Bethge, Ulrike ; Migschitz, Brigitte ; Fasching, Sabine ; Walch, Axel ; Herbst, Friedrich ; Teleky, Bela ; Wrba, Fritz</creator><creatorcontrib>Kaserer, Klaus ; Schmaus, Judith ; Bethge, Ulrike ; Migschitz, Brigitte ; Fasching, Sabine ; Walch, Axel ; Herbst, Friedrich ; Teleky, Bela ; Wrba, Fritz</creatorcontrib><description>Immunohistochemistry (IHC) is a cheap and rapid method to detect p53 inactivation but the results are often discordant with gene mutation analysis. This study aimed to investigate whether there is a difference in the immunohistochemical staining patterns of p53‐positive cells on comparing tumours with inactivating gene mutations with those without. Tissues of 142 colorectal cancers were investigated for p53 inactivation simultaneously by IHC and gene analysis using SSCP of exons 4–9 and sequencing. In addition, tumours were investigated immunohistochemically for the expression of mdm‐2 protein, known to be transcriptionally transactivated by the wild‐type (wt) p53 gene. p53‐positive cells of tumours without detectable p53 gene mutations were microdissected using a PALM laser microscope system and subjected to p53 sequence analysis. Among the 142 cases of colorectal cancer (male/female=88/54; mean age 66a±11 years, range 24–90 years), 74% (n=105) of tumours were positive by p53 IHC and mutations in the p53 gene were found in 51% (73 patients). In 16% (12 patients) with mutations in the p53 gene, IHC for p53 was negative. In tumours with mutations in the p53 gene and positive p53 IHC, staining of all nuclei of the tumour was more frequently (57/61, 93%) found than in tumours without p53 gene mutations, where staining of scattered single cells was predominantly seen (29/44, 66%; p<0.0001). mdm‐2 positivity (n=33) showed only staining of scattered single cells, predominantly (24/33, 82%; p<0.0001) in tumours without gene mutations. Single cell microdissection followed by mutation analysis of scattered p53‐positive cells revealed no gene mutations. A scattered positive immunohistochemical reactivity of p53 in colorectal cancer cells might therefore represent a functionally active non‐mutated p53 gene and should not be considered as a marker of gene mutation and inactivation. Copyright © 2000 John Wiley & Sons, Ltd.</description><identifier>ISSN: 0022-3417</identifier><identifier>EISSN: 1096-9896</identifier><identifier>DOI: 10.1002/(SICI)1096-9896(200003)190:4<450::AID-PATH545>3.0.CO;2-8</identifier><identifier>PMID: 10699994</identifier><identifier>CODEN: JPTLAS</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>Adenocarcinoma - genetics ; Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; colonic adenocarcinoma ; Colorectal Neoplasms - genetics ; DNA Mutational Analysis ; DNA, Neoplasm - analysis ; Female ; Gastroenterology. Liver. Pancreas. Abdomen ; Gene Silencing - physiology ; Genes, p53 - genetics ; Humans ; Immunohistochemistry ; Male ; mdm-2 ; mdm-2 protein ; Medical sciences ; Middle Aged ; Mutation - genetics ; p53 ; SSCP ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Tumors</subject><ispartof>The Journal of pathology, 2000-03, Vol.190 (4), p.450-456</ispartof><rights>Copyright © 2000 John Wiley & Sons, Ltd.</rights><rights>2000 INIST-CNRS</rights><rights>Copyright 2000 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4705-b2a19c0849b9c5de3a298338d8eab716885e5faf4409993ca8881c40ac89f63a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1297210$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10699994$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kaserer, Klaus</creatorcontrib><creatorcontrib>Schmaus, Judith</creatorcontrib><creatorcontrib>Bethge, Ulrike</creatorcontrib><creatorcontrib>Migschitz, Brigitte</creatorcontrib><creatorcontrib>Fasching, Sabine</creatorcontrib><creatorcontrib>Walch, Axel</creatorcontrib><creatorcontrib>Herbst, Friedrich</creatorcontrib><creatorcontrib>Teleky, Bela</creatorcontrib><creatorcontrib>Wrba, Fritz</creatorcontrib><title>Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer</title><title>The Journal of pathology</title><addtitle>J. Pathol</addtitle><description>Immunohistochemistry (IHC) is a cheap and rapid method to detect p53 inactivation but the results are often discordant with gene mutation analysis. This study aimed to investigate whether there is a difference in the immunohistochemical staining patterns of p53‐positive cells on comparing tumours with inactivating gene mutations with those without. Tissues of 142 colorectal cancers were investigated for p53 inactivation simultaneously by IHC and gene analysis using SSCP of exons 4–9 and sequencing. In addition, tumours were investigated immunohistochemically for the expression of mdm‐2 protein, known to be transcriptionally transactivated by the wild‐type (wt) p53 gene. p53‐positive cells of tumours without detectable p53 gene mutations were microdissected using a PALM laser microscope system and subjected to p53 sequence analysis. Among the 142 cases of colorectal cancer (male/female=88/54; mean age 66a±11 years, range 24–90 years), 74% (n=105) of tumours were positive by p53 IHC and mutations in the p53 gene were found in 51% (73 patients). In 16% (12 patients) with mutations in the p53 gene, IHC for p53 was negative. In tumours with mutations in the p53 gene and positive p53 IHC, staining of all nuclei of the tumour was more frequently (57/61, 93%) found than in tumours without p53 gene mutations, where staining of scattered single cells was predominantly seen (29/44, 66%; p<0.0001). mdm‐2 positivity (n=33) showed only staining of scattered single cells, predominantly (24/33, 82%; p<0.0001) in tumours without gene mutations. Single cell microdissection followed by mutation analysis of scattered p53‐positive cells revealed no gene mutations. A scattered positive immunohistochemical reactivity of p53 in colorectal cancer cells might therefore represent a functionally active non‐mutated p53 gene and should not be considered as a marker of gene mutation and inactivation. Copyright © 2000 John Wiley & Sons, Ltd.</description><subject>Adenocarcinoma - genetics</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>colonic adenocarcinoma</subject><subject>Colorectal Neoplasms - genetics</subject><subject>DNA Mutational Analysis</subject><subject>DNA, Neoplasm - analysis</subject><subject>Female</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Gene Silencing - physiology</subject><subject>Genes, p53 - genetics</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Male</subject><subject>mdm-2</subject><subject>mdm-2 protein</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mutation - genetics</subject><subject>p53</subject><subject>SSCP</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Tumors</subject><issn>0022-3417</issn><issn>1096-9896</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNqFkVFv0zAUhSMEYmXwF1AeENoeUuzYju2CEKWwrVJFJ1bEBA9Xruu0hjQpdirov-eWlIEE0vxyrXuPj47vlySvKOlTQvJnJ1fj0fiUEl1kWuniJCd42CnVZMBfcEEGg-H4TXY5nF0ILl6yPumPps_zTN1JejeP7iY9tMozxqk8Sh7E-AU9tBbifnJESaHx8F6yuGqNr329TDembV2oY9qU6Uaw1K_X27pZ-dg2duXWWMMuNfUibVfOh3Tum6pZemuqNPpl7Uu81talvk4tToKzLY5-9cLD5F5pqugeHepx8uHs7Wx0kU2m5-PRcJJZLonI5rmh2hLF9VxbsXDM5FoxphbKmbmkhVLCidKUnOM_NLNGKUUtJ8YqXRbMsOPkaee7Cc23rYstYGzrqsrUrtlGkERzqaW4VUilIEKqAoXXndCGJsbgStgEvzZhB5TAHhXAHhXstw77rUOHChAVcEBUAIgKDqiAAYHRFHJQaP34kGE7X7vFX8YdGxQ8OQhMxDWXAXfp4x9drmVOCco-d7LvvnK7f_LdFu__6X630D3r3JG_-3HjbsJXKCSTAj6-O4fXs09nl3zyHq7ZT_TCzPc</recordid><startdate>200003</startdate><enddate>200003</enddate><creator>Kaserer, Klaus</creator><creator>Schmaus, Judith</creator><creator>Bethge, Ulrike</creator><creator>Migschitz, Brigitte</creator><creator>Fasching, Sabine</creator><creator>Walch, Axel</creator><creator>Herbst, Friedrich</creator><creator>Teleky, Bela</creator><creator>Wrba, Fritz</creator><general>John Wiley & Sons, Ltd</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>200003</creationdate><title>Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer</title><author>Kaserer, Klaus ; Schmaus, Judith ; Bethge, Ulrike ; Migschitz, Brigitte ; Fasching, Sabine ; Walch, Axel ; Herbst, Friedrich ; Teleky, Bela ; Wrba, Fritz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4705-b2a19c0849b9c5de3a298338d8eab716885e5faf4409993ca8881c40ac89f63a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adenocarcinoma - genetics</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>colonic adenocarcinoma</topic><topic>Colorectal Neoplasms - genetics</topic><topic>DNA Mutational Analysis</topic><topic>DNA, Neoplasm - analysis</topic><topic>Female</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Gene Silencing - physiology</topic><topic>Genes, p53 - genetics</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Male</topic><topic>mdm-2</topic><topic>mdm-2 protein</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mutation - genetics</topic><topic>p53</topic><topic>SSCP</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kaserer, Klaus</creatorcontrib><creatorcontrib>Schmaus, Judith</creatorcontrib><creatorcontrib>Bethge, Ulrike</creatorcontrib><creatorcontrib>Migschitz, Brigitte</creatorcontrib><creatorcontrib>Fasching, Sabine</creatorcontrib><creatorcontrib>Walch, Axel</creatorcontrib><creatorcontrib>Herbst, Friedrich</creatorcontrib><creatorcontrib>Teleky, Bela</creatorcontrib><creatorcontrib>Wrba, Fritz</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kaserer, Klaus</au><au>Schmaus, Judith</au><au>Bethge, Ulrike</au><au>Migschitz, Brigitte</au><au>Fasching, Sabine</au><au>Walch, Axel</au><au>Herbst, Friedrich</au><au>Teleky, Bela</au><au>Wrba, Fritz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer</atitle><jtitle>The Journal of pathology</jtitle><addtitle>J. Pathol</addtitle><date>2000-03</date><risdate>2000</risdate><volume>190</volume><issue>4</issue><spage>450</spage><epage>456</epage><pages>450-456</pages><issn>0022-3417</issn><eissn>1096-9896</eissn><coden>JPTLAS</coden><abstract>Immunohistochemistry (IHC) is a cheap and rapid method to detect p53 inactivation but the results are often discordant with gene mutation analysis. This study aimed to investigate whether there is a difference in the immunohistochemical staining patterns of p53‐positive cells on comparing tumours with inactivating gene mutations with those without. Tissues of 142 colorectal cancers were investigated for p53 inactivation simultaneously by IHC and gene analysis using SSCP of exons 4–9 and sequencing. In addition, tumours were investigated immunohistochemically for the expression of mdm‐2 protein, known to be transcriptionally transactivated by the wild‐type (wt) p53 gene. p53‐positive cells of tumours without detectable p53 gene mutations were microdissected using a PALM laser microscope system and subjected to p53 sequence analysis. Among the 142 cases of colorectal cancer (male/female=88/54; mean age 66a±11 years, range 24–90 years), 74% (n=105) of tumours were positive by p53 IHC and mutations in the p53 gene were found in 51% (73 patients). In 16% (12 patients) with mutations in the p53 gene, IHC for p53 was negative. In tumours with mutations in the p53 gene and positive p53 IHC, staining of all nuclei of the tumour was more frequently (57/61, 93%) found than in tumours without p53 gene mutations, where staining of scattered single cells was predominantly seen (29/44, 66%; p<0.0001). mdm‐2 positivity (n=33) showed only staining of scattered single cells, predominantly (24/33, 82%; p<0.0001) in tumours without gene mutations. Single cell microdissection followed by mutation analysis of scattered p53‐positive cells revealed no gene mutations. A scattered positive immunohistochemical reactivity of p53 in colorectal cancer cells might therefore represent a functionally active non‐mutated p53 gene and should not be considered as a marker of gene mutation and inactivation. Copyright © 2000 John Wiley & Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><pmid>10699994</pmid><doi>10.1002/(SICI)1096-9896(200003)190:4<450::AID-PATH545>3.0.CO;2-8</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0022-3417 |
| ispartof | The Journal of pathology, 2000-03, Vol.190 (4), p.450-456 |
| issn | 0022-3417 1096-9896 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70947975 |
| source | Wiley-Blackwell Read & Publish Collection |
| subjects | Adenocarcinoma - genetics Adult Aged Aged, 80 and over Biological and medical sciences colonic adenocarcinoma Colorectal Neoplasms - genetics DNA Mutational Analysis DNA, Neoplasm - analysis Female Gastroenterology. Liver. Pancreas. Abdomen Gene Silencing - physiology Genes, p53 - genetics Humans Immunohistochemistry Male mdm-2 mdm-2 protein Medical sciences Middle Aged Mutation - genetics p53 SSCP Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Tumors |
| title | Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T02%3A22%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Staining%20patterns%20of%20p53%20immunohistochemistry%20and%20their%20biological%20significance%20in%20colorectal%20cancer&rft.jtitle=The%20Journal%20of%20pathology&rft.au=Kaserer,%20Klaus&rft.date=2000-03&rft.volume=190&rft.issue=4&rft.spage=450&rft.epage=456&rft.pages=450-456&rft.issn=0022-3417&rft.eissn=1096-9896&rft.coden=JPTLAS&rft_id=info:doi/10.1002/(SICI)1096-9896(200003)190:4%3C450::AID-PATH545%3E3.0.CO;2-8&rft_dat=%3Cproquest_cross%3E17505786%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4705-b2a19c0849b9c5de3a298338d8eab716885e5faf4409993ca8881c40ac89f63a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17505786&rft_id=info:pmid/10699994&rfr_iscdi=true |